Biofrontera (BFRI) Enterprise Value (2020 - 2026)
Biofrontera (BFRI) posted quarterly Enterprise Value of -$6.4 million for Q4 2025, down 8.41% year-over-year from -$7.0 million in Q4 2024, and down 87.01% quarter-over-quarter from -$3.4 million in Q3 2025.
Biofrontera (BFRI) Enterprise Value (2020 - 2026) Analysis & Trends
Biofrontera's Enterprise Value history runs 6 years deep, the most recent figure standing at -$6.4 million for Q4 2025.
- In Q4 2025, Enterprise Value fell 8.41% year-over-year to -$6.4 million; the TTM figure through Dec 2025 stood at -$6.4 million (down 8.41% YoY), while the FY2025 annual figure was -$6.4 million, down 8.41% from the prior year.
- Enterprise Value for Q4 2025 stood at -$6.4 million, down from -$3.4 million in the prior quarter.
- The five-year high for Enterprise Value was -$1.4 million in Q4 2023, with the low at -$31.9 million in Q2 2022.
- The 5-year median for Enterprise Value is -$6.4 million (2025), against an average of -$11.1 million.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value sank 1502.56% in 2022, then surged 94.88% in 2023.
- Biofrontera's Enterprise Value stood at -$24.5 million in 2021, then declined by 13.29% to -$27.8 million in 2022, then soared by 94.88% to -$1.4 million in 2023, then sank by 316.05% to -$5.9 million in 2024, then slipped by 8.41% to -$6.4 million in 2025.
- Business Quant data shows BFRI's Enterprise Value at -$6.4 million in Q4 2025, -$3.4 million in Q3 2025, and -$7.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Biofrontera | 18.87 Mn | 14.16 Mn | 9.59 Mn | -4.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.71 Mn |
| Dec 31, 2025 | -6.41 Mn |
| Sep 30, 2025 | -3.43 Mn |
| Jun 30, 2025 | -7.21 Mn |
| Mar 31, 2025 | -1.81 Mn |
| Dec 31, 2024 | -5.91 Mn |
| Sep 30, 2024 | -2.88 Mn |
| Jun 30, 2024 | -4.39 Mn |
| Mar 31, 2024 | -3.84 Mn |
| Dec 31, 2023 | -1.42 Mn |
| Sep 30, 2023 | -6.72 Mn |
| Mar 31, 2023 | -8.90 Mn |
| Dec 31, 2022 | -27.76 Mn |
| Sep 30, 2022 | -27.50 Mn |
| Jun 30, 2022 | -31.91 Mn |
| Mar 31, 2022 | -22.40 Mn |
| Dec 31, 2021 | -24.50 Mn |
| Sep 30, 2021 | -1.72 Mn |
| Dec 31, 2020 | -8.10 Mn |